Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Growth in Short Interest

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the recipient of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 766,100 shares, an increase of 21.1% from the November 15th total of 632,500 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Ascentage Pharma Group International Price Performance

OTCMKTS:ASPHF opened at $6.45 on Monday. Ascentage Pharma Group International has a twelve month low of $6.45 and a twelve month high of $6.45. The company’s 50 day moving average is $5.77 and its two-hundred day moving average is $3.78.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.